Login to Your Account

Genta Receives Ganite Approval In Cancer-Related Hypercalcemia

By Kim Coghill

Friday, September 19, 2003
Genta Inc. received its first drug approval Thursday when the FDA cleared Ganite for the treatment of cancer-related hypercalcemia that is resistant to hydration. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription